Professional Resource Guide: Drug-Free Workplace: Employee Education

This article, the first in a two-part series, reviews and examines the components of clinical nutrition. In Part 1, the authors introduce the concept of nutrition and the role it plays in supporting healthy employees, current guidelines, and recommendations for determining healthy eating and the nutritional component of carbohydrates. In Part 2, the components of fats, proteins, vitamins, minerals, and water, and a resource guide are provided for the occupational health nurse to assist in the implementation of employee education in the area of healthy nutrition. The intent of the articles is to acquaint and inform occupational health nurses on the current guidelines for healthy eating so they can better appraise their employee population, thus creating a healthier workforce. The information provided is not all-inclusive on the topics discussed, but provides a foundation to understand the requirements for a healthier workforce.

Download Full-text

OASAS Professional Resource Guide: Drug-Free Workplace: Supervisor Training

PsycEXTRA Dataset ◽

10.1037/e358612004-001 ◽

2013 ◽

Author(s):

Keyword(s):

Supervisor Training ◽

Resource Guide ◽

Drug Free

Download Full-text

Comprehensive Review of Nutrition Components for Occupational Health Nurses—Part 2

Workplace Health & Safety ◽

10.1177/2165079918780846 ◽

2018 ◽

Vol 66 (11) ◽

pp. 545-559

Author(s):

Noreen Chikotas ◽

Rebecca Toothaker

Keyword(s):

Occupational Health ◽

Healthy Eating ◽

Employee Education ◽

Resource Guide ◽

Comprehensive Review ◽

Nutritional Components ◽

Healthy Nutrition ◽

Health Nurse ◽

Occupational Health Nurse ◽

Current Guidelines

This article, the second in a two-part series, reviews and examines the components of clinical nutrition. In Part 2, the authors discuss nutritional components of fats, proteins, vitamins, minerals, and water. A resource guide is provided for the occupational health nurse to assist in the implementation of employee education in the area of healthy nutrition. The intent of the articles is to acquaint and inform the occupational health nurse on the current guidelines for healthy eating so she or he can better appraise their employee population, thus creating a healthier workforce. The information provided is not all-inclusive on the topics discussed but it provides a foundation for a better understanding of the requirements for healthy eating.

Download Full-text

An Overview of Occupational Alcoholism Issues for the 80's

Journal of Drug Education ◽

10.2190/7h7v-cf6c-aypq-kkej ◽

1982 ◽

Vol 12 (1) ◽

pp. 1-27 ◽

Cited By ~ 14

Author(s):

Keith McClellan

Keyword(s):

Job Performance ◽

Insurance Coverage ◽

Work Force ◽

Employee Assistance ◽

Employee Education ◽

Family Disruption ◽

The Past ◽

Start Up ◽

Drug Free ◽

The U.S

The past decade has been a period of learning and experimentation in occupational alcoholism and employee assistance programming (EAPs). Assumptions regarding the essential ingredients for such program's sponsorship and principal targets, changed during this period. The professionalization of the U.S. work force is thought to require further modification of EAP casefinding. Future EAPs are expected to place less emphasis on supervisory confrontation than on broader types of casefinding. Early identification, prior to a decline in job performance, is anticipated. Employee involvement, attention to poly-drug addiction, family disruption, employee education, and the need for drug-free lifestyles are essential for future programs to succeed and labor law needs to be considered when employee organizations attempt to operate EAPs. EAP consortia are seen as a method of reaching the bulk of the work force. Start-up capital and uniform insurance coverage are unsolved problems for consortia.

Download Full-text

Effect of piperacillin on morphology and viability of gram-negative bacteria

Proceedings, annual meeting, Electron Microscopy Society of America ◽

10.1017/s0424820100111203 ◽

1984 ◽

Vol 42 ◽

pp. 218-219

Author(s):

R. H. Liss

Keyword(s):

Inhibitory Concentration ◽

Cytoplasmic Membrane ◽

Drug Binding ◽

Gram Negative Bacteria ◽

Bacterial Cells ◽

Drug Induced ◽

Penicillin Binding Proteins ◽

Lactam Antibiotic ◽

Drug Free ◽

Tube Dilution

Piperacillip (PIP) is b-[D(-)-α-(4-ethy1-2,3-dioxo-l-piperzinylcar-bonylamino)-α-phenylacetamido]-penicillanate. The broad spectrum semisynthetic β-lactam antibiotic is believed to effect bactericidal activity through its affinity for penicillin-binding proteins (PBPs), enzymes on the bacterial cytoplasmic membrane that control elongation and septation during cell growth and division. The purpose of this study was to correlate penetration and binding of 14C-PIP in bacterial cells with drug-induced lethal changes assessed by microscopic, microbiologic and biochemical methods.The bacteria used were clinical isolates of Escherichia coli and Pseudomonas aeruginosa (Figure 1). Sensitivity to the drug was determined by serial tube dilution in Trypticase Soy Broth (BBL) at an inoculum of 104 organisms/ml; the minimum inhibitory concentration of piperacillin for both bacteria was 1 μg/ml. To assess drug binding to PBPs, the bacteria were incubated with 14C-PIP (5 μg/0.09 μCi/ml); controls, in drug-free medium.

Download Full-text

The Antiaggressive Action of Combined Haloperidol-Propranolol Treatment in Schizophrenia

European Psychologist ◽

10.1027//1016-9040.5.4.312 ◽

2000 ◽

Vol 5 (4) ◽

pp. 312-325 ◽

Cited By ~ 9

Author(s):

Gadi Maoz ◽

Daniel Stein ◽

Sorin Meged ◽

Larisa Kurzman ◽

Joseph Levine ◽

...

Keyword(s):

Rating Scales ◽

Double Blind ◽

Propranolol Group ◽

Schizophrenic Patients ◽

Propranolol Treatment ◽

Simultaneous Decrease ◽

The Mean ◽

Haloperidol Treatment ◽

To Receive ◽

Drug Free

Psychopharmacological interventions for managing aggression in schizophrenia have thus far yielded inconsistent results. This study evaluates the antiaggressive efficacy of combined haloperidol-propranolol treatment. Thirty-four newly admitted schizophrenic patients were studied in a controlled double-blind trial. Following a 3-day drug-free period and 7 days of haloperidol treatment, patients were randomly assigned to receive either haloperidol-propranolol or haloperidol-placebo for eight consecutive weeks. Doses of medications were adjusted as necessary; biperiden was administered if required. Rating scales were applied to assess aggression, anger, psychosis, depression, anxiety and extrapyramidal symptoms. The mean daily dose of haloperidol was 21 mg (SD = 6.4) in the research group and 29 mg (SD = 6.9) in the controls. Mean and maximal daily doses of propranolol were 159 mg (SD = 61) and 192 mg (SD = 83), and of placebo, 145 mg (SD = 50) and 180 mg (SD = 70), respectively. Compared with the controls, the scores for the research patients decreased significantly from baseline, particularly after 4 weeks of treatment, for some dimensions of anger, psychosis, anxiety, and neuroleptic-induced parkinsonism. A tendency for reduced aggression was shown in the combined haloperidol-propranolol group for some dimensions but not others. These patients also required significantly less biperiden. The tendency toward elevated antiaggressive effect of combined haloperidol-propranolol treatment compared to haloperidol alone may be explained by a simultaneous decrease in aggression, psychotic symptomatology, and anxiety.

Download Full-text